Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-Q

(Mark One)

[X]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
     For the quarterly period ended September 30, 2002

OR

[   ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     For the transition period from _______ to _______

Commission File Number 000-31523

IXIA
(Exact name of registrant as specified in its charter)

     
California
(State or other jurisdiction of
incorporation or organization)
  95-4635982
(I.R.S. Employer Identification No.)

26601 West Agoura Road, Calabasas, CA 91302
(Address of principal executive offices, including zip code)

(818) 871-1800
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]      No [   ]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

     
Common Stock
(Class of Common Stock)
  57,536,757
(Outstanding at November 4, 2002)



 


TABLE OF CONTENTS

Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Income
Condensed Consolidated Statements of Cash Flows
Notes to Condensed Consolidated Financial Statements
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 4. CONTROLS AND PROCEDURES
PART II. OTHER INFORMATION
ITEM 5. Other Information
ITEM 6. Exhibits and Reports on Form 8-K
SIGNATURES
CERTIFICATIONS
Exhibit 99.1
Exhibit 99.2


Table of Contents

IXIA

TABLE OF CONTENTS

             
            Page Number
           
PART I.   FINANCIAL INFORMATION    
 
    Item 1.   Financial Statements (unaudited)    
 
        Condensed Consolidated Balance Sheets as of September 30, 2002 and December 31, 2001   3
 
        Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2002 and 2001   4
 
        Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2002 and 2001   5
 
        Notes to Condensed Consolidated Financial Statements   6
 
    Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   10
 
    Item 3.   Quantitative and Qualitative Disclosures about Market Risk   15
 
    Item 4.   Controls and Procedures   15
 
PART II.   OTHER INFORMATION    
 
    Item 5.   Other Information   15
 
    Item 6.   Exhibits and Reports on Form 8-K   16
 
SIGNATURES   17
 
CERTIFICATIONS   18

2


Table of Contents

IXIA
Condensed Consolidated Balance Sheets
(in thousands)

                     
        September 30,   December 31,
        2002   2001
       
 
        (unaudited)        
Assets
               
Current assets:
               
 
Cash and cash equivalents
  $ 70,867     $ 116,643  
 
Short-term investments in securities
    15,118        
 
Accounts receivable, net of allowance for doubtful accounts of $373 and $467 as of September 30, 2002 and December 31, 2001, respectively
    10,367       7,534  
 
Inventories
    5,557       3,316  
 
Income taxes receivable
    664       2,598  
 
Prepaid expenses and other current assets
    4,062       4,460  
 
   
     
 
   
Total current assets
    106,635       134,551  
Investments in securities
    31,687        
Property and equipment, net
    7,577       6,821  
Goodwill
    2,451       848  
Intangible assets, net
    5,036       1,688  
Other assets, net
    567       258  
 
   
     
 
   
Total assets
  $ 153,953     $ 144,166  
 
   
     
 
Liabilities and Shareholders’ Equity
               
Current liabilities:
               
 
Accounts payable
  $ 937     $ 1,482  
 
Accrued expenses
    4,387       3,317  
 
Deferred revenues
    1,704       1,546  
 
   
     
 
   
Total liabilities
    7,028       6,345  
 
   
     
 
Shareholders’ equity:
               
 
Common stock, without par value; 200,000 shares authorized, 57,280 and 55,810 shares issued and outstanding as of September 30, 2002 and December 31, 2001, respectively
    78,733       77,764  
 
Additional paid-in capital
    46,729       46,933  
 
Deferred stock-based compensation
    (4,264 )     (9,418 )
 
Retained earnings
    25,727       22,542  
 
   
     
 
   
Total shareholders’ equity
    146,925       137,821  
 
   
     
 
   
Total liabilities and shareholders’ equity
  $ 153,953     $ 144,166  
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

3


Table of Contents

IXIA
Condensed Consolidated Statements of Income
(in thousands, except per share data)

(unaudited)

                                       
          Three months ended   Nine months ended
          September 30,   September 30,
         
 
          2002   2001   2002   2001
         
 
 
 
Net revenues
  $ 16,864     $ 16,183     $ 49,560     $ 60,152  
Cost of revenues(1)
    3,417       3,604       9,777       12,885  
 
   
     
     
     
 
   
Gross profit
    13,447       12,579       39,783       47,267  
Operating expenses:(1)
                               
 
Research and development
    5,178       4,434       15,132       14,339  
 
Sales and marketing
    5,191       4,558       15,161       15,430  
 
General and administrative
    1,899       1,808       5,837       6,817  
 
Amortization of purchased intangible assets
    258             684        
 
   
     
     
     
 
     
Total operating expenses
    12,526       10,800       36,814       36,586  
 
   
     
     
     
 
   
Income from operations
    921       1,779       2,969       10,681  
Interest income, net
    692       961       2,071       3,306  
 
   
     
     
     
 
   
Income before income taxes
    1,613       2,740       5,040       13,987  
Income tax expense
    459       1,077       1,855       7,526  
 
   
     
     
     
 
   
Net income
  $ 1,154     $ 1,663     $ 3,185     $ 6,461  
 
   
     
     
     
 
Earnings per share:
                               
 
Basic
  $ 0.02     $ 0.03     $ 0.06     $ 0.12  
 
Diluted
  $ 0.02     $ 0.03     $ 0.05     $ 0.10  
Weighted average number of common and common equivalent shares outstanding:
                               
 
Basic
    57,137       54,965       56,724       54,270  
 
Diluted
    60,162       61,087       60,625       62,041  
 

(1) Stock-based compensation included in:
                               
   
Cost of revenues
  $ 74     $ 160     $ 314     $ 574  
   
Research and development
    593       1,217       2,356       4,872  
   
Sales and marketing
    272       697       1,072       2,744  
   
General and administrative
    148       288       544       1,889  
 
   
     
     
     
 
 
  $ 1,087     $ 2,362     $ 4,286     $ 10,079  
 
   
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

4


Table of Contents

IXIA
Condensed Consolidated Statements of Cash Flows
(in thousands)

(unaudited)

                         
            Nine months ended
            September 30,
           
            2002   2001
           
 
Cash flows from operating activities:
               
 
Net income
  $ 3,185     $ 6,461  
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
   
Depreciation and amortization
    3,805       1,952  
   
Provision for doubtful accounts
          387  
   
Stock-based compensation
    4,286       10,079  
   
Interest receivable from shareholders
          (8 )
   
Changes in operating assets and liabilities:
               
     
Accounts receivable
    (2,833 )     2,367  
     
Inventories
    (2,241 )     1,657  
     
Income taxes receivable
    2,598       2,569  
     
Prepaid expenses and other current assets
    398       460  
     
Other assets
    (309 )     (24 )
     
Accounts payable
    (545 )     (2,959 )
     
Accrued expenses
    1,070       (1,652 )
     
Deferred revenue
    (171 )     (149 )
     
Income taxes payable
          (2,029 )
 
   
     
 
       
Net cash provided by operating activities
    9,243       19,111  
 
   
     
 
Cash used in investing activities:
               
 
Purchases of property and equipment
    (3,929 )     (5,045 )
 
Purchases of investments
    (68,340 )      
 
Proceeds from redemption of investments
    21,535        
 
Payments in connection with acquisition
    (5,254 )      
 
   
     
 
       
Cash used in investing activities
    (55,988 )     (5,045 )
 
   
     
 
Cash flows from financing activities:
               
 
Proceeds from exercise of stock options
    969       1,488  
 
Proceeds from related-party notes receivable
          270  
 
   
     
 
       
Net cash provided by financing activities
    969       1,758  
 
   
     
 
       
Net increase (decrease) in cash and cash equivalents
    (45,776 )     15,824  
Cash and cash equivalents at beginning of period
    116,643       96,066  
 
   
     
 
Cash and cash equivalents at end of period
  $ 70,867     $ 111,890  
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

5


Table of Contents

IXIA

Notes to Condensed Consolidated Financial Statements

September 30, 2002
(unaudited)

1. Business

     Ixia (the “Company”) was incorporated on May 27, 1997 as a California corporation. The Company develops, markets and sells high-speed, distributed, multiport traffic generators and performance analyzers for wire-speed verification of optical networking equipment, LAN, MAN, and WAN multi-layer switches and routers. Our customers include manufacturers of network equipment, Internet and network service providers, communications chip manufacturers and network users.

2. Basis of Presentation

     The accompanying consolidated financial statements as of September 30, 2002 and for the three and nine months ended September 30, 2002 and 2001, are unaudited and reflect all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the Company’s financial position, operating results and cash flows for the interim periods presented. The results of operations for the current interim periods presented are not necessarily indicative of results to be expected for the full year ending December 31, 2002 or any other future period.

     These consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2001.

3. Investments

     The Company’s investments as of September 30, 2002 consisted of held-to-maturity U.S. government debt and corporate debt securities. Held-to-maturity securities are carried at amortized cost. Amortization of the purchase discounts and premiums is included in interest income. Realized gains and losses and declines in value judged to be other than temporary are included in results of operations. Realized gains and losses are calculated using the specific identification method and were not material to the Company’s results of operations in any period presented.

     Investments as of September 30, 2002 consisted of the following (in thousands):

                       
          Carrying   Fair
          Value   Value
         
 
Held-to-maturity investments:
               
 
Maturities within one year:
               
   
U.S. government debt securities
  $ 12,089     $ 12,110  
   
Corporate debt securities
    3,029       3,031  
 
   
     
 
 
    15,118       15,141  
 
   
     
 
 
Maturities after one year through three years:
               
   
U.S. government debt securities
    13,096       13,303  
   
Corporate debt securities
    18,591       18,956  
 
   
     
 
 
    31,687       32,259  
 
   
     
 
     
Total investments
  $ 46,805     $ 47,400  
 
   
     
 

6


Table of Contents

IXIA

Notes to Condensed Consolidated Financial Statements

4. Inventories

     Inventories consist of the following (in thousands):

                 
    September 30,   December 31,
    2002   2001
   
 
Raw materials
  $ 1,988     $ 1,502  
Work in process
    897       1,510  
Finished goods
    2,672       304  
 
   
     
 
 
  $ 5,557     $ 3,316  
 
   
     
 

5. Earnings per Share

     Basic earnings per share is based on the weighted average number of common shares outstanding during the period. Diluted earnings per share is based on the weighted average number of common shares and dilutive potential common shares outstanding during the period.

     The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2002 and 2001 (in thousands, except per share data):

                                     
        Three months ended   Nine months ended
        September 30,   September 30,
       
 
        2002   2001   2002   2001
       
 
 
 
Basic presentation
                               
Numerator:
                               
 
Net income
  $ 1,154     $ 1,663     $ 3,185     $ 6,461  
Denominator:
                               
 
Weighted average common shares
    57,221       55,124       56,827       54,543  
 
Adjustment for common shares subject to repurchase
    (84 )     (159 )     (103 )     (273 )
 
   
     
     
     
 
Denominator for basic calculation
    57,137       54,965       56,724       54,270  
 
   
     
     
     
 
Basic earnings per share
  $ 0.02     $ 0.03     $ 0.06     $ 0.12  
 
   
     
     
     
 
Diluted presentation
                               
Denominator:
                               
 
Shares used above
    57,137       54,965       56,724       54,270  
 
Weighted average effect of dilutive securities:
                               
   
Stock options and warrants
    2,941       5,963       3,798       7,498  
   
Common shares subject to repurchase
    84       159       103       273  
 
   
     
     
     
 
Denominator for diluted calculation
    60,162       61,087       60,625       62,041  
 
   
     
     
     
 
Diluted earnings per share
  $ 0.02     $ 0.03     $ 0.05     $ 0.10  
 
   
     
     
     
 

6. Related Party Transactions

     Revenues from a subsidiary of a company in which a director/shareholder of the Company is a director and significant shareholder, and in which two director/shareholders of the Company are directors, totaled $235,000 and $354,000 for the three months ended September 30, 2002 and 2001, respectively, and $1.6 million and $827,000 for the nine months ended September 30, 2002 and 2001, respectively. Related party accounts receivable as of December 31, 2001 was $168,000. As of September 30, 2002, there were no related party accounts receivable and the subsidiary had been sold to an unrelated third party.

7


Table of Contents

IXIA

Notes to Condensed Consolidated Financial Statements

7. Concentrations

International Revenues:

     Net revenues from international product shipments were $3.2 million and $2.7 million for the three months ended September 30, 2002 and 2001, respectively, and $11.1 million and $9.2 million for the nine months ended September 30, 2002 and 2001, respectively.

Credit Risk:

     Financial instruments which subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short and long term investments and trade accounts receivable. The Company maintains its cash and cash equivalents with reputable financial institutions, and at times, cash balances may be in excess of the FDIC insurance limits. The Company maintains a portfolio of investments in a variety of investment-grade securities, including corporate and U.S. debt securities, and with a variety of issuers. The Company extends differing levels of credit to customers, does not require collateral deposits and maintains reserves for potential credit losses based upon the expected collectibility of accounts receivable. Credit losses to date have been within management’s expectations and have not been significant.

     For the three and nine months periods ended September 30, 2002 and 2001, only one customer comprised more than 10% of net revenues as follows (in thousands, except percentages):

                                 
    Three months ended   Nine months ended
    September 30,   September 30,
   
 
    2002   2001   2002   2001
   
 
 
 
Amount of net revenues
  $ 5,314     $ 4,075     $ 16,987     $ 14,218  
As a percentage of total net revenues
    32 %     25 %     34 %     24 %

     As of September 30, 2002 and December 31, 2001, the Company had receivable balances from the customer approximating 23% and 18%, respectively, of total accounts receivable.

8. Acquisition

     On February 14, 2002, the Company completed the acquisition of the assets of the ANVL (Automated Network Validation Library) product line from Empirix, Inc. ANVL protocol conformance testing products are used by network equipment manufacturers in the development of networking devices to validate protocol implementation. The results of the ANVL product line have been included in the Company’s consolidated financial statements since the acquisition date. The results of operations of the ANVL product line for all periods presented were not material to the Company and accordingly, proforma results of operations have not been presented.

     The aggregate cash purchase price was $5.2 million. In addition, a contingent cash payment of up to $1.0 million may be paid based upon sales through March 31, 2003 of ANVL products and services. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands):

8


Table of Contents

IXIA

Notes to Condensed Consolidated Financial Statements

         
Property and equipment
  $ 64  
Intangible assets
    3,830  
Goodwill
    1,592  
 
   
 
Total assets acquired
    5,486  
Current liabilities assumed
    (329 )
 
   
 
Net assets acquired
  $ 5,157  
 
   
 

     The acquired intangible assets consisted of $3.2 million for unpatented technology and $592,000 for a non-compete covenant. The unpatented technology and the non-compete covenant are being amortized using a straight-line method over their expected useful lives of seven and three years, respectively. Total amortization expense during the three and nine months ended September 30, 2002 totaled $165,000 and $412,000, respectively.

9


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

     The following discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors. The results of operations for the three and nine months ended September 30, 2002, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2002, or of any other future period. The following discussion should be read in conjunction with the consolidated financial statements and the notes thereto included in Item 1 of this Quarterly Report and in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2001, including the “Risk Factors” section and the consolidated financial statements and notes included therein.

OVERVIEW

     We develop, market and sell high-speed, distributed, multiport traffic generators and performance analyzers for wire-speed verification of optical networking equipment, LAN, MAN, and WAN multi-layer switches and routers. Our products allow customers to generate network and Internet protocol traffic and analyze the performance, accuracy and reliability of equipment and systems that they either manufacture for sale to others or purchase for use in their own networks. Our customers include manufacturers of network equipment, Internet and network service providers, communications chip manufacturers and network users.

     Our product offerings include a variety of interface cards, chassis that hold the interface cards and related software products. Our interface cards utilize a variety of interfaces — Packet Over SONET, BERT, Ethernet and USB. The following table sets forth, for the periods indicated, our net revenues by principal product category in dollars and as a percentage of total net revenues:

                                                                 
    Three months ended   Nine months ended
    September 30,   September 30,
   
 
Products   2002   2001   2002   2001

 
 
 
 
    (in thousands, except percentages)
Optical interface cards
  $ 8,768       52.0 %   $ 10,234       63.2 %   $ 27,470       55.4 %   $ 37,967       63.1 %
Electrical interface cards
    4,788       28.4       3,775       23.3       13,484       27.2       13,988       23.3  
Chassis, software and other products
    3,308       19.6       2,174       13.5       8,606       17.4       8,197       13.6  
 
   
     
     
     
     
     
     
     
 
Total
  $ 16,864       100.0 %   $ 16,183       100.0 %   $ 49,560       100.0 %   $ 60,152       100.0 %
 
   
     
     
     
     
     
     
     
 

     Sales to our five largest customers collectively accounted for approximately $8.4 million or 49.9% of our net revenues for the three months ended September 30, 2002 and $6.7 million or 41.2% of our net revenues for the three months ended September 30, 2001. Sales to our five largest customers collectively accounted for approximately $25.0 million or 50.4% of our net revenues for the nine months ended September 30, 2002 and $21.8 million or 36.3% of our net revenues for the nine months ended September 30, 2001. To date, we have sold our systems primarily to network equipment manufacturers. While we expect that we will continue to have some customer concentration for the foreseeable future, we continue to sell our systems to a wide variety of customers and to the extent we develop a broader and more diverse customer base, we anticipate that our reliance on any one customer will diminish.

     Net revenues. Our revenues consist primarily of product and software sales. Our product sales include hardware and software components that are sold as an integrated system. Our software products are primarily installed on and used in conjunction with our hardware products. Our software does not require significant modification or customization, and our sales do not involve any significant future obligations or customer acceptance terms. Accordingly, product revenue from product sales is recognized upon shipment. We warrant the hardware and software components of our products for up to one year after sale. At the time of sale we defer that portion of our revenues that relates to our post-contract support and recognize it ratably over the service period. Revenues from maintenance contracts are deferred and recognized ratably over the term of the contracts.

10


Table of Contents

     Cost of Revenues. Our cost of revenues consists of materials, payments to third party manufacturers, salaries and related expenses for manufacturing personnel and the warranty cost of hardware to be replaced during the warranty period. We outsource the majority of our manufacturing operations, and we conduct final assembly, supply chain management, quality assurance, documentation control and shipping at our facility. Accordingly, a significant portion of our cost of revenues consists of payments to our contract manufacturers. In addition, cost of revenues includes a non-cash component related to the amortization of deferred stock-based compensation related to manufacturing personnel.

     Gross Margins. Excluding the effects of stock-based compensation, the gross margins of our various interface cards have generally been consistent and have exceeded the gross margins of our chassis. In general, our gross margins are primarily affected by the following factors:

          the pricing we are able to obtain from our component suppliers and contract manufacturers;
 
          the mix of our products sold;
 
          new product introductions by us and by our competitors;
 
          production volume;
 
          changes in our pricing policies and those of our competitors;
 
          demand for our products; and
 
          the mix of sales channels through which our products are sold.

     Operating Expenses. We generally recognize our operating expenses as we incur them in three general operational categories: research and development, sales and marketing and general and administrative. Our operating expenses also include a non-cash component related to the amortization of deferred stock-based compensation related to research and development, sales and marketing and general and administrative personnel.

     Research and development expenses consist primarily of salaries and related personnel and consulting costs related to the design, development, testing and enhancements of our systems. We expense our research and development costs as they are incurred. We also capitalize and depreciate over a two-year period some costs of our systems used for internal purposes.

     Sales and marketing expenses consist primarily of salaries, commissions and related expenses for personnel engaged in sales and marketing and customer support functions, as well as costs associated with promotional and other marketing activities.

     General and administrative expenses consist primarily of salaries and related expenses for executive, finance, human resources, information technology and administrative personnel, as well as recruiting and professional fees, insurance costs and other general corporate expenses, including rent.

     Deferred stock-based compensation represents the difference between the deemed fair value of our common stock for accounting purposes and (1) the exercise price of the options and warrants at the date of grant or (2) the purchase price of the restricted stock. At the date of grant deferred stock-based compensation is presented as a reduction of shareholders’ equity, with amortization recorded over the vesting period, which is typically four years. Deferred stock-based compensation at September 30, 2002 decreased from deferred stock-based compensation at June 30, 2002 by $98,000 and from December 31, 2001 by $467,000 as a result of the forfeiture of stock options and changes in the market value of the Company’s common stock that affected certain equity instruments which receive variable accounting treatment. Deferred stock-based compensation at September 30, 2001 decreased from deferred stock-based compensation at June 30, 2001 by $450,000 and from December 31, 2000 by $1.7 million as a result of the forfeiture of stock options and changes in the market value of the Company’s common stock that affected certain equity instruments which receive variable accounting treatment. We amortized to the respective expense categories $1.1 million of deferred stock-based compensation in the three months ended September 30, 2002 and $2.4 million

11


Table of Contents

in the three months ended September 30, 2001. We amortized to the respective expense categories $4.3 million of deferred stock-based compensation in the nine months ended September 30, 2002 and $10.1 million in the nine months ended September 30, 2001. Based on the unvested options, warrants and stock subject to repurchase as of September 30, 2002, we expect to record additional stock-based compensation expense relating to deferred stock-based compensation approximately as follows: $1.2 million during the remaining three months of 2002, $2.6 million during 2003 and $492,000 during 2004. The amount of deferred stock-based compensation expense to be recorded in future periods could decrease if options and stock subject to repurchase for which unearned compensation has been recorded are forfeited or repurchased. Changes in the market value of the Company’s common stock could also affect future stock-based compensation expense related to equity instruments which receive variable accounting treatment.

RESULTS OF OPERATIONS

     The following table sets forth certain statement of operations data as a percentage of net revenues for the periods indicated:

                                       
          Three months ended   Nine months ended
          September 30,   September 30,
         
 
          2002   2001   2002   2001
         
 
 
 
Net revenues
    100.0 %     100.0 %     100.0 %     100.0 %
Cost of revenues(1)
    20.3       22.3       19.7       21.4  
 
   
     
     
     
 
   
Gross profit
    79.7       77.7       80.3       78.6  
Operating expenses:(1)
                               
 
Research and development
    30.7       27.4       30.5       23.9  
 
Sales and marketing
    30.8       28.1       30.6       25.7  
 
General and administrative
    11.3       11.2       11.8       11.3  
 
Amortization of purchased intangible assets
    1.5       0.0       1.4       0.0  
 
   
     
     
     
 
     
Total operating expenses
    74.3       66.7       74.3       60.9  
 
   
     
     
     
 
   
Income from operations
    5.4       11.0       6.0       17.7  
Interest income, net
    4.1       6.0       4.2       5.5  
 
   
     
     
     
 
   
Income before income taxes
    9.5       17.0       10.2       23.2  
Income tax expense
    2.7       6.7       3.8       12.5  
 
   
     
     
     
 
   
Net income
    6.8 %     10.3 %     6.4 %     10.7 %
 
   
     
     
     
 

(1) Stock-based compensation included in:
                               
   
Cost of revenues
    0.4 %     1.0 %     0.6 %     1.0 %
   
Research and development
    3.4       7.5       4.7       8.1  
   
Sales and marketing
    1.6       4.3       2.2       4.6  
   
General and administrative
    0.9       1.8       1.1       3.1  
 
   
     
     
     
 
 
    6.3 %     14.6 %     8.6 %     16.8 %
 
   
     
     
     
 

Comparison of Three and Nine Months Ended September 30, 2002 and 2001

     Net Revenues. In the third quarter of 2002, net revenues increased 4.2% to $16.9 million from the $16.2 million recorded in the third quarter of 2001. This increase was primarily related to the introduction of new product lines and sales to new customers. In the first nine months of 2002, net revenues decreased 17.6% to $49.6 million from the $60.2 million recorded in the first nine months of 2001. This decrease was primarily related to a broad reduction of customer orders across all product lines due to a slowdown in the economy and in spending by data networking and telecommunication companies.

12


Table of Contents

     Gross Profit. In the third quarter of 2002, gross profit increased 6.9% to $13.4 million from the $12.6 million recorded in the third quarter of 2001. For the first nine months of 2002, gross profit decreased 15.8% to $39.8 million from the $47.3 million recorded in the first nine months of 2001. Excluding stock-based compensation, gross profit as a percentage of net revenues increased in the third quarter of 2002 to 80.2% from 78.7% for the third quarter of 2001. Excluding stock-based compensation, gross profit as a percentage of net revenues increased in the first nine months of 2002 to 80.9% from 79.5% for the first nine months of 2001. This increase in the gross profit percentages was primarily a result of decreasing component costs, and to a lesser extent, to an increase in sales of high margin software products during the first nine months of 2002, as compared to the first nine months of 2001.

     Research and Development Expenses. In the third quarter of 2002, research and development expenses increased 16.8% to $5.2 million from the $4.4 million recorded in the third quarter of 2001. For the first nine months of 2002, research and development expenses increased 5.5% to $15.1 million from the $14.3 million recorded in the first nine months of 2001. Excluding stock-based compensation related to individuals engaged in research and development activities, research and development expenses increased 42.5% to $4.6 million in the three months ended September 30, 2002 from $3.2 million in the three months ended September 30, 2001 and 35.0% to $12.8 million in the nine months ended September 30, 2002 from $9.5 million in the nine months ended September 30, 2001. This increase was primarily a result of higher compensation and related benefit costs due to the addition of engineering personnel through internal hiring and acquisitions and the use of third party consultants.

     Sales and Marketing Expenses. In the third quarter of 2002, sales and marketing expenses increased 13.9% to $5.2 million from the $4.6 million recorded in the third quarter of 2001. For the first nine months of 2002, sales and marketing expenses decreased 1.7% to $15.2 million from the $15.4 million recorded in the first nine months of 2001. Excluding stock-based compensation related to individuals engaged in sales and marketing activities, sales and marketing expenses increased 27.4% to $4.9 million in the three months ended September 30, 2002 from $3.9 million in the three months ended September 30, 2001 and 11.1% to $14.1 million in the nine months ended September 30, 2002 from $12.7 million in the nine months ended September 30, 2001. This increase was primarily due to increased compensation and related benefit costs as a result of increases in the number of direct sales and marketing personnel.

     General and Administrative Expenses. In the third quarter of 2002, general and administrative expenses increased 5.0% to $1.9 million from the $1.8 million recorded in the third quarter of 2001. In the first nine months of 2002, general and administrative expenses decreased 14.4% to $5.8 million from the $6.8 million recorded in the first nine months of 2001. Excluding stock-based compensation related to personnel engaged in general and administrative activities, general and administrative expenses increased 15.2% to $1.8 million in the three months ended September 30, 2002 from $1.5 million in the three months ended September 30, 2001 and 7.4% to $5.3 million in the nine months ended September 30, 2002 from $4.9 million in the nine months ended September 30, 2001. This increase was primarily a result of increases in insurance, property tax, utilities and rent expenses.

     Amortization of Purchased Intangible Assets. Amortization of purchased intangible assets increased to $258,000 for the three months ended September 30, 2002 and to $684,000 for the nine months ended September 30, 2002. There was no amortization of intangible assets in the three or nine months ended September 30, 2001. This increase was a result of acquisition of Caimis Inc. in November 2001 and the acquisition of the assets of the ANVL product line from Empirix, Inc. in February of 2002.

     Interest Income, Net. Net interest income decreased to $692,000 for the three months ended September 30, 2002 from $961,000 for the three months ended September 30, 2001. Net interest income decreased to $2.1 million for the first nine months of 2002 from $3.3 million for the first nine months of 2001. This decrease was primarily the result of a decline in short-term interest rates. We incurred minimal interest expense in the three and nine months ended on each of September 30, 2002 and 2001.

     Income Tax Expense. Income tax expense decreased to $459,000, or an effective rate of 28.5%, for the three months ended September 30, 2002 from $1.1 million, or an effective rate of 39.3%, for the three months ended September 30, 2001. Income tax expense decreased to $1.9 million, or an effective rate of 36.8%, for the nine months ended September 30, 2002 from $7.5 million, or an effective rate of 53.8%, for the nine months ended

13


Table of Contents

September 30, 2001. The differences between the effective rates and the statutory rates were primarily due to the impact of non-deductible stock-based compensation charges, offset by research and development credits.

LIQUIDITY AND CAPITAL RESOURCES

     Net cash provided by operating activities was $9.2 million in the nine months ended September 30, 2002 and $19.1 million in the nine months ended September 30, 2001. Net cash generated from operations in the nine months ended September 30, 2002 and 2001 was primarily provided by net income adjusted for non-cash expenses and offset by an increase in working capital requirements.

     Cash used in investing activities was $56.0 million in the nine months ended September 30, 2002 and $5.0 million in the nine months ended September 30, 2001. For the nine months ended September 30, 2002, cash used in investing activities consisted of $46.8 million for the net purchases of investment securities, $5.3 million in connection with the acquisition of the assets of the ANVL product line from Empirix, Inc., and $3.9 million for the acquisition of property and equipment. For the nine months ended September 30, 2001, cash used in investing activities consisted exclusively of capital expenditures related to the acquisition of property and equipment.

     Financing activities provided net cash of $969,000 in the nine months ended September 30, 2002 and consisted exclusively of proceeds from the exercise of stock options. Financing activities in the nine months ended September 30, 2001 provided net cash of $1.8 million and consisted of proceeds from related party receivables and the exercise of stock options.

     We believe that our existing balances of cash and cash equivalents, investments and cash flows expected to be generated from our operations will be sufficient to meet our cash needs for working capital and capital expenditures for at least the next 12 months, although we could be required, or could elect, to seek additional funding prior to that time. Our capital requirements will depend on many factors, including the growth rate of our net revenues, our profitability, our capital expenditures, working capital requirements, the timing and extent of spending to support product development efforts and the expansion of our sales, marketing and technical support efforts.

SAFE HARBOR UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995:

     The statements that are not historical facts in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and other sections of this Quarterly Report are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and are subject to the safe harbor created by that Section. Words such as “may,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “potential” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. These risks, uncertainties and other factors may cause our actual results, performances or achievements to be materially different from those expressed or implied by our forward-looking statements and include, among other things: the current global economic slowdown in general and decreasing capital availability and investment in the telecommunications and data communications industries in particular, consistency of orders from significant customers, the timing of new product releases, our success in developing and producing new products, market acceptance of our products and competitive pressures including competition for limited source components. Many of these risks and uncertainties are outside of our control and are difficult for us to forecast or mitigate. Factors that may cause our actual results to differ materially from our forward-looking statements include the risks and other factors set forth in the “Risk Factors” and other sections of the Company’s Annual Report on Form 10-K for the year ended December 31, 2001.

14


Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Sensitivity

     The primary objective of our investment activities is to maintain the safety of principal and preserve liquidity while maximizing yields without significantly increasing risk. Some of the securities that we have invested in may be subject to market risk. This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate. To minimize this risk, we maintain our portfolio of cash equivalents and investments in a variety of securities, including commercial paper, government debt securities, corporate debt securities and money market funds. We do not use any derivatives or similar instruments to manage our interest rate risk. The Company has the positive intent and ability to hold these securities to maturity. Currently, the carrying amount of these securities approximates fair market value. However, the fair market value of these securities is subject to interest rate risk and would decline in value if market interest rates increased. If market interest rates were to increase immediately and uniformly by 10 percent from the levels as of September 30, 2002, the decline in the fair market value of the portfolio would not be material to the Company’s financial position, results of operations or cash flows.

Exchange Rate Sensitivity

     Currently all of our sales and the majority of our expenses are denominated in U.S. dollars and, as a result, we have not experienced significant foreign exchange gains and losses to date. While we conducted some transactions in foreign currencies during the nine months ended September 30, 2002 and expect to continue to do so, we do not anticipate that foreign exchange gains or losses will be significant. We have not engaged in foreign currency hedging to date, but we may do so in the future.

ITEM 4. CONTROLS AND PROCEDURES

     (a) Evaluation of Disclosure Controls and Procedures

     As of a date within 90 days prior to the filing date of this quarterly report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s President and Chief Executive Officer and its Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” as defined in Exchange Act Rule 13a-14. Based upon that evaluation, the Company’s President and Chief Executive Officer and its Chief Financial Officer concluded that the Company’s disclosure controls and procedures are adequate and effective in timely alerting them to material information relating to the Company and its consolidated subsidiaries required to be included in the Company’s periodic SEC filings.

     (b) Changes in Internal Controls

     There have been no significant changes in our internal controls or in other factors that could significantly affect our internal controls subsequent to the date of the evaluation referred to above.

PART II. OTHER INFORMATION

ITEM 5. Other Information

     Our policy governing transactions in our securities by our directors, officers and employees permits such persons to adopt stock trading plans pursuant to Rule 10b5-1 promulgated by the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Errol Ginsberg, our President and Chief Executive Officer, has (through his affiliated family trust) adopted a Rule 10b5-1 stock trading plan and has made and may continue to make periodic sales of our Common Stock under such plan. We anticipate that from time to time in the future other directors, officers and employees of the Company may establish such stock trading plans.

15


Table of Contents

We do not undertake any obligation to update or revise our disclosure regarding these plans and specifically do not undertake to disclose the amendment, termination or expiration of any such plans, except as may be required by law.

ITEM 6. Exhibits and Reports on Form 8-K

        (a)    Exhibits
 
             99.1 Certificate of Chief Executive Officer of Ixia pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
             99.2 Certificate of Chief Financial Officer of Ixia pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
        (b)    Reports on Form 8-K.
 
             Ixia filed a report on Form 8-K on August 13, 2002 with respect to the certifications of its Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed under Item 9 of Form 8-K)

16


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  IXIA

 

 
Date:   November 12, 2002   By:   /s/ Errol Ginsberg
   
     
            Errol Ginsberg
President and Chief Executive Officer

 
Date:   November 12, 2002   By:   /s/ Thomas B. Miller
   
     
            Thomas B. Miller
Chief Financial Officer

17


Table of Contents

CERTIFICATIONS

I, Errol Ginsberg, certify that:

         
1.   I have reviewed this quarterly report on Form 10-Q of Ixia;
         
2.   Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
         
3.   Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
         
4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
         
    a)   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
         
    b)   evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
         
    c)   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
         
5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
         
    a)   all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
         
    b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and
         
6.   The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: November 12, 2002  

 
  /s/ Errol Ginsberg
 
Errol Ginsberg
President and Chief Executive Officer

18


Table of Contents

I, Thomas B. Miller, certify that:

         
1.   I have reviewed this quarterly report on Form 10-Q of Ixia;
     
2.   Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
     
3.   Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
     
4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
         
    a.   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
         
    b.   evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
         
    c.   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
     
5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
         
    a.   all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
         
    b.   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and
     
6.   The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: November 12, 2002  

 
  /s/ Thomas B. Miller
 
Thomas B. Miller
Chief Financial Officer

19